1. Fludarabine and Pharmacokinetic-Targeted Busulfan before Allografting for Adults with Acute Lymphoid Leukemia 
Stella Santarone, Joseph Pidala, Marta Di Nicola, Teresa Field, Melissa Alsina, Ernesto Ayala, William Janssen, Mohamed A. Kharfan- Dabaja, Leonel Ochoa, Lia Perez, Janelle Perkins, Jyoti Raychaudhuri, Hugo Fernandez, Claudio Anasetti 
Biology of Blood and Marrow Transplantation 
Volume 17, Issue 10, Pages (October 2011)
DOI: /j.bbmt
Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Cumulative incidence of nonrelapse mortality according to age <35 (solid line) vs. age ≥35 (dashed line), P = .73.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Cumulative incidence of relapse, stratified according to remission status at time of transplant (solid line = CR1, dashed line = more advanced disease, including CR2 and -3, and primary induction failure), P = .036 for comparison.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Overall survival, stratified by remission status at time of transplant (dashed line = CR1, solid line = more advanced disease), log-rank P = .06.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions

5. Figure 4
(A) Relapse-free survival from date of transplantation, stratified by remission status (dashed line = CR1, solid line = more advanced disease), log-rank P = .09. (B) Relapse-free survival from date of transplantation, stratified by age (solid line = age <35, dashed line = age ≥35), log-rank P = .79.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions